Tergus Pharma - Topical Drug Manufacturer

In semi-solid formulations, the release rate of an API gets influenced by both structural and physical properties. For all forms of solid oral dosage forms, dissolution testing gets done throughout the drug development process. Dissolution testing detects physical changes in API. For non-oral dosage forms and semi-solid topical formulations, IVRT gets done to examine drug-releasing properties. It is an efficient tool to evaluate the release rate and diffusion of API in topical products. 

Franz diffusion cells, tissues are constructed, a biological sample, like cadaver skin, and a non-interactive synthetic membrane gets used to measure the drug release rate in this method. You can analyze a range of semi-solid dosage forms. These are creams, ointments, lotions, hydrogels, suspensions, topical aerosols, liposomes microencapsulation, and many more. It not only evaluates drug release from semi-solid drug products but is also a correctly validated method to assess manufacturing quality. It is often included as a compulsory test in various cases and will soon become a required part of the regulatory package. 

FDA publishes the guidance of IVRT for various domains. In May 1997, it released its guidance for industry, Scale-Up, and Post-approval changes: Chemistry, Manufacturing, and Controls (CMC), In-vitro release testing, and In Vivo Bioequivalence Documentation for Non-sterile semi-solid dosage forms (SUPAC-SS). It defined the following postulates.

Levels of change

CMC tests to support each level of change

Recommend various in vitro and in vivo bioequivalence tests to support each level of change

Documents in favor of the change

 Various specific guidelines have been launched by the FDA lately. These particular guidelines aim to overcome barriers in the development of generics and improve patient care. The industries that involve bioequivalence (BE) assessments via in vitro or in vivo permeation methods use these clear and strict guidelines. 

In Vitro Permeation Testing or IVPT studies, biological membranes for formulations get applied on the affective skin areas and the eyes. Skin and eyes are sensitive parts of our body that react immediately to a drug reaction. Guidance is crucial for product development and establishing the bioequivalence of the products. This permeation test provides the maximum degree of success that is necessary for NCE or ANDA filing. It uses formulation development and robust methods in combination with the QbD guidelines to yield optimized test results. Optimization of analytical, receiver buffer, and dose amount along with other study conditions. 

In vitro permeation testing is desirable due to the following reasons.

The method gives prime focus to sensitivity and selectivity.

Only optimized assay parameters qualify the process. 

Validation is the key here. Validation of analytical method, test system, mass balance, recovery, and dose depletion gets done.

You can rely on this method for pivotal bioequivalence comparison of parallel, single-dose, and multiple donors. The comparison reports support statistical evaluation.

Study conditions like time point selection, dosage amount, dosage form, and receiver medium are highly optimized. 

 There is an importance of using in vitro permeation testing with a reliable source. The following points are relevant examples of their extensive applications.

This method understands the two most basic things, namely the capability of the formulation to reach the active site with the body and elicit its therapeutic effect. The fundamental understanding of these abilities of a formulation help in the development and establishing product equivalence. 

Here, dermal tissue or rabbit cornea and conjunctiva can get used. It means that the testing utilizes clinical endpoints and uses pharmacokinetic studies.

As the name of the test suggests, you can use it for permeation. Apart from that, it can be used for studying drug accumulation in different layers of dermal tissue. 

The leading topical drug manufacturers have experienced a profit of 95.2 billion USD in the year 2020. According to statistics, experts estimate that the market will reach a profit of 129.8 billion USD by the end of 2025. The growth in this market is driven by the high soft tissue and skin infection prevalence. However, the alternative drug delivery presence modes like injectable and oral routes are expected to restrain the market growth during the forecasting segment.

According to the findings, the topical drug manufacturer can expect to grow in this market at CAGR 6 to 7% rate in the coming two years. According to the analysts, the below aspects play a primary role in shaping global market growth. 

High Skin disease prevalence 

Various skin diseases, like eczema, vitiligo, and skin cancer, have become one of the leading causes of non-fatal diseases and have affected a large number of the global population. Almost 2 to 3 million people suffer due to non-melanoma skin cancer, and psoriasis disease will become one of the most serious concerns in the world. The topical drug manufacturer will be the first line of defense in these cases to deliver all the topical drugs for the skin disease treatment. The demand for topical drugs will also improve in the coming years.

Biologics delivery through the transdermal route

The biologics delivery by the topical drug companies through the transdermal route has become one of the emerging trends in the drug delivery market. The large molecule transdermal delivery, like subcutaneous, intravenous, or intramuscular administration routes, will offer significant benefits to the patient through cost-efficient treatment and painless drug deliveries.

Both physical and structural properties of a person can influence the API or Active Pharmaceutical Ingredient release rate in all the semisolid drug topical formulations. Measurement of the API is exceptionally critical throughout the development of the drug lifecycle and the processes. It begins from the initial phase of the selection of clinical candidates till the setting of the specifications in the late developmental segment. It also includes changes or modifications in the products and post-approval QC. In the topical formulations of the semi-solid drugs, In-Vitro Release Testing or IVRT is becoming a more vital and prevalent tool for determining the API diffusion and the release rate in the topical products. 

Explanation of the IVRT process

During the drug development lifecycle and process, dissolution testing detects the physical changes in the drug formulation and the API, necessary for all oral solid dosages. Similarly, for the non-oral doses, including the topical formulations of the semi-solid drugs, in-vitro testing is required for evaluating the properties in the drug releases. IVRT measures the drug release rate by implementing the Franz diffusion cells and a non-interactive synthetic skin or membrane and is used for developing the methods. It analyzes the various ranges of semi-solid dosages, which include:

Creams

Lotions

Suspensions

Ethosomes or Liposomes

Ointments

Hydrogels

Topical Aerosols

Microencapsulation

IVRT Guidance and Testing

FDA has already released the guidance for the post-approval and scale-up guidance of the industry. IVRT identifies the non-sterile semi-solid dosage forms with the intended topical administration route, which might include:

Change in the levels

CMC level to support every change level

Suggested IVRT or in vivo bioequivalence tests to support every change level

Documentation supporting the change

IVRT (In Vitro Release Testing) plays an indispensable role when it comes to analyzing the release performance and also drug test diffusion. It works effectively in saving both cost and time, especially when compared to those of traditional bioequivalence studies. The said testing method also has a crucial role in ensuring both consistency and also quality in the manufacturing process.

Being a highly result-oriented research and development method, IVRT is useful in developing and optimizing formulations while letting you provide complete quality control too. It helps in monitoring the production quality with time.

As a result-oriented method, IVRT also determines the rate of drug release. Besides, the process also works when it comes to choosing a clinical candidate with QbD (Quality by Design) principles. Besides, it’s also effective in serving as a cost-effective method for analyzing products.

What is the Theory and Principle of IVRT?

A proper IVRT method is related to mimicking skin permeation kinetics such as membrane, donor, and a complete receptor medium, which is determined for drug concentration. Besides, drug release from various semisolid dosage forms generally follows a simple equation of Higuchi.

The equation is: Q = 2C0 • (Dt/n)1/2

One can use this equation mostly in the condition of the solubilized drug in the released drug and formation matrix. The drug quantity that is released during the experiment is directly proportional to the square root of time.

Tergus Provides FDA-approved IVRT Test

If any pharmaceutical company is seeking to have a partnership with topical CDMO, they need to be aware of its several advantages. Manufacturing new drugs is a complicated process and it’s certainly not possible for every pharmaceutical company to handle the same. We are going to dive into numerous advantages related to partnering with CDMO. Take a look.

Vast Expertise

CDMOs indeed possess huge expertise when it comes to carrying out drug development and manufacturing. They have a dynamic team of chemists, researchers, and also drug manufacturing professionals. It enables them to carry out the topical formulation development efficiently while ensuring success.

Scalability

When it comes to CDMO manufacturers, these are popular for having immense capabilities of helping those of pharmaceutical companies scale. Outsourcing pharmaceutical manufacturing helps businesses scale irrespective of their size. Whether you are a large or a small pharmaceutical company, you can approach CDMOs for drug development irrespective of your budget.

Equipment and Accessories

This is another most vital reason why any pharmaceutical company needs to get in touch with CDMOs. These service providers have cutting-edge equipment and accessories that streamline the drug development and manufacturing process.

Apart from this, various pharmaceutical companies often face complex decisions when they wish to improve their capabilities, introduce or also manufacturing drugs at different costs. In nutshell, getting in touch with topical pharmaceutical CDMO helps companies in accessing world-class equipment and facilities even without investing in it.

Things to Look for When Hiring a CDMO Partner

For hiring a new CDMO partner, you need to take into account numerous points. Let’s take a look at it all.

Experience

Technical Expertise

Staff needs to own technical acumen

Contract development and manufacturing company is popularly represented as CDMO in a short form in the pharmaceutical industry. The company is responsible for rendering services like drug manufacturing. The pharmaceutical company approaches CDMO for the main purpose of outsourcing their task drug manufacturing and development.

CDMO offering full service generally covers different aspects of drug development and also manufacturing. Besides, they work based on the needs and expectations of their customer clients and helps them accomplishing the task successfully.

Services CDMOs Offer

Well, a pharmaceutical company approaches topical CMDO for numerous services. Some of these are the following.

Formulation

For topical formulation development, CDMO needs to go through several steps like API stability test, formulation components blending, blend coating using casting knife, coated film lamination with backing, etc.

Coating

Be it narrow or width coating, topical pharmaceutical CDMO does everything based on their needs. For this, they need to adjust the temperature of their equipment. It can be low as 100-degree F or high can be 350-degree F.

Shipment

When it comes to shipping, the CDMOs are always ready to cater to the specific shipment needs of every client. It endeavors to help clients receive products within the committed time while ensuring their complete satisfaction.

Analytical Services

Analytical services involve analyzing the plates that CDMOs use. Many times, these plates get scratches that tend to impact results to a wider extent.

Blending

As the name suggests, blending is all about combining both equipment and process. CDMOs have mixing vessels with different capacities.

Converting

It’s another service CDMOs render. The process involves focusing on the products that have been visually inspected.  

Sterilization

For sterilization, the CDMOs generally use machines called Optel. One can set it up with a work or test environment for getting the same outcome.

Packaging

The topical pharmaceutical product formulation is something that is meant to be used for the treatment of different indications be it systematic or local. Be it facilitating patient compliance, easy to deliver, avoiding the major issue of the first-pass metabolism, the topical pharmaceutical CDMO is known for having its numerous advantages.

This formulation tends to be in different forms, including creams, liquid, or gels. You can also find it in a semisolid form. No matter which formation you are going to develop, you need to have a sound understanding of release characteristics, physicochemical properties, nature of the drug, drug-delivery composition, etc.

CMC strategy becomes vital and needs to be implemented properly if you wish to manufacture a semisolid dosage. The strategy works effectively not only in reducing the process of impurities but also for ensuring physical stability, efficacy, etc.

For tropical drug formulation, it’s a great idea to get in touch with a company that has vast experience in this arena. The company can handle the process with efficiency and delivers successful results. Make sure the company you are hiring for topical pharmaceutical CDMO is FDA-registered and has a full-fledged GMP-compliant laboratory.

The company should have cutting-edge instruments and also a highly skilled team that possesses proficiency in handling the operation no matter how complicated it is. Whether you are looking to just revamp you’re ongoing production process or wish to formulate your new topical product, the company needs to have a sufficient resource to accomplish the same. It’s a good idea to check all these things before you hire the company.

Topical formulation development is known for having numerous advantages. Some of its advantages include easy delivery, get rid of first-pass metabolism, patient compliance, etc. You need to also know that topical formulation is available in different forms be it liquid, gels, semi-solid, or creams. One needs to have a sound knowledge of release characteristics, physiochemical characteristics, drug delivery system composition, etc.

Apart from this, organoleptic characteristics also keep great importance. You need to create a CMC strategy for processing to produce semisolid dosage. All you need to do is to make sure the CMC strategy is implemented properly as it has a crucial role in ensuring physical stability, efficacy, minimize the impurity process, etc.

Well, it’s fact that topical formulation development is a highly expensive process. So, one needs to get the helping hand of a reliable and expert pharmaceutical company like Tergus Pharma. The company has earned vast expertise in the process of topical drug production. It employs a dynamic team and indeed cutting-edge instrument to handle the manufacturing process of even those of complex topical formulation.

Tergus Pharma offers you the right assistance whether you are looking for streamlining your manufacturing process or formulating a new topical product. The company has adequate resources to offer you the right assistance.

The company works with a proven strategy for handling various complicated projects be it topical formulation for emulsions, gels, sprays, or creams. It is familiar with the efficacy and also stability of the product based on various factors that include mixing time, a method for mixing, temperature, cooling rate, etc. The company makes the best utilization of equipment that helps it in getting the précise control over numerous factors for creating a complete manufacturing process.

In vitro release testing involves letting the pharmaceutical industry for conducting repeatable, quick, and indeed highly controllable tests. These tissues or also called cells are developed in the lab, which helps in getting details about effects even without the necessity of living subjects.

If we talk about the neuropharmacology sector, it has also adopted IVRT testing and made huge investments into the same. The investment helped them in getting details about various compounds, especially during the POC phase. Another great thing about in vitro testing is that it is not so expensive and everyone can afford it easily. One can easily set up, repeatable, control, compared to even those of animal studies. The test is capable of proving its mechanism of action or also for discovering various neurotoxic effects in the earlier process before the testing is performed.

Meanwhile, in vitro testing also comes with several setbacks. In vitro testing generally uses materials derived from those of actual animal or human tissues to more closely model neuronal activity. Besides, it also provides a close match to those of functioning human brain compared to the animal model.

As far as a response is concerned, in vitro tends to be completely different, especially when the same intervention is used for an integrated system. Apart from this, even the advanced models are not able to make an accurate assessment of the complicated neuronal action.

As far as in vitro studies are concerned, these are speedy and not so expensive. Besides, one can set up it without any hustle when compared to in vivo testing. Besides this, it requires a limited amount of testing material as well.

Tergus Pharma offers a comprehensive topical CDMO solution that serves as a one-stop-shop for pharmaceutical companies in the US Market.

Tergus offers comprehensive solutions for your topical formulation development needs. We are the top leading experts in delivering a full range of Active Pharmaceutical Ingredients.